Risk-treatment mismatch for heart failure

被引：1
|
作者：
Suissa, S [1 ]
机构：
[1] Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 24期
关键词：
D O I：
10.1001/jama.294.24.3087-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3087 / 3087
页数：1
相关论文
共 50 条
  • [41] Growing Mismatch Between Evidence Generation and Implementation in Heart Failure
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Butler, Javed
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (05): : 525 - 527
  • [42] Risk Profiles in Heart Failure Baseline, Residual, Worsening, and Advanced Heart Failure Risk
    Greene, Stephen J.
    Fonarow, Gregg C.
    Butler, Javed
    CIRCULATION-HEART FAILURE, 2020, 13 (06)
  • [43] Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
    von Haehling, Stephan
    Assmus, Birgit
    Bekfani, Tarek
    Dworatzek, Elke
    Edelmann, Frank
    Hashemi, Djawid
    Hellenkamp, Kristian
    Kempf, Tibor
    Raake, Philipp
    Schuett, Katharina A.
    Wachter, Rolf
    Schulze, Paul Christian
    Hasenfuss, Gerd
    Boehm, Michael
    Bauersachs, Johann
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (09) : 1287 - 1305
  • [44] Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure
    Pozzoli, Massimo
    Gonzalez-Costello, Jose
    Bayes-Genis, Antoni
    Sinagra, Gianfranco
    Anker, Stefan D.
    Coats, Andrew J. S.
    Crespo-Leiro, Marisa G.
    Filippatos, Gerasimos
    Laroche, Cecile
    Maggioni, Aldo P.
    Mebazaa, Alexandre
    Piepoli, Massimo F.
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 906 - 910
  • [45] Atrial fibrillation and congestive heart failure: Risk factors, mechanisms, and treatment
    Heist, EK
    Ruskin, JN
    PROGRESS IN CARDIOVASCULAR DISEASES, 2006, 48 (04) : 256 - 269
  • [46] Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
    Urbanek, Irmina
    Kaczmarek, Krzysztof
    Cygankiewicz, Iwona
    Ptaszynski, Pawel
    DRUG HEALTHCARE AND PATIENT SAFETY, 2014, 6 : 47 - 54
  • [47] Risk-Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention: An Opportunity for Quality Improvement
    Wimmer, Neil J.
    Mauri, Laura
    Matheny, Michael E.
    Pomerantsev, Eugene
    Ho, Kalon K.
    Robbins, Susan
    Matteau, Alexis
    Vasaiwala, Samip
    Resnic, Frederic S.
    Yeh, Robert W.
    CIRCULATION, 2012, 126 (21)
  • [48] Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary Syndromes
    Roe, Matthew T.
    Marquis-Gravel, Guillaume
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (11) : 1462 - 1464
  • [49] Obesity and the risk of heart failure
    Kenchaiah, S
    Vasan, SR
    BIOMEDICINE & PHARMACOTHERAPY, 2003, 57 (02) : 110 - 110
  • [50] The risk-treatment paradox in acute coronary syndrome patients: insights from the FORCE-ACS registry
    Azzahhafi, J.
    Van der Sangen, N. M. R.
    Yin, D. R. P. P. Chan Pin
    Henriques, J. P. Simao
    Kikkert, W. J.
    Ten Berg, J. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1406 - 1406
12345